PGEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Precigen Inc (PGEN) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive technical signals, weak financial performance, and absence of significant catalysts suggest holding off on this stock for now.
The MACD histogram is negative (-0.125), indicating bearish momentum. RSI is neutral at 23.671, and moving averages are converging, signaling no clear trend. The stock is trading near its support level (S1: 3.368), which may provide some stability, but overall, the technical indicators do not suggest a strong buy opportunity.
Revenue increased significantly by 206.61% YoY in Q3 2025, showing some growth potential.
Hedge funds are selling heavily, with an 801.59% increase in selling activity over the last quarter. Gross margin dropped significantly (-1198.30% YoY), and net income remains deeply negative (-$325.34M). No recent news or significant insider activity to drive positive sentiment.
In Q3 2025, revenue grew by 206.61% YoY to $2.92M, but net income remains negative at -$325.34M, albeit improving by 1256.84% YoY. EPS is still negative at -1.06, despite a 1077.78% YoY improvement. Gross margin dropped significantly to 64.58, down -1198.30% YoY, indicating operational inefficiencies.
No recent analyst rating or price target changes are available for analysis.
